Tert-Butyl Rosuvastatin: A Key Intermediate in Cardiovascular Drug Development
Understanding the properties and applications of Tert-Butyl Rosuvastatin (CAS 355806-00-7) for enhanced lipid management therapies.
Get a Quote & SampleProduct Core Value
Tert-Butyl Rosuvastatin
Tert-Butyl Rosuvastatin, identified by CAS 355806-00-7, is a significant derivative of Rosuvastatin, widely recognized for its role as an HMG-CoA reductase inhibitor. This compound is not only a key metabolite but also an important impurity that plays a crucial role in the synthesis and quality control of Rosuvastatin-based cardiovascular disease medications.
- Understanding the synthesis of Tert-Butyl Rosuvastatin is vital for pharmaceutical manufacturers aiming to produce high-purity Rosuvastatin intermediates.
- The application of Tert-Butyl Rosuvastatin in combination with pemafibrate or its salts highlights its role in advanced cardiovascular disease medication development.
- Investigating the chemical properties of Tert-Butyl Rosuvastatin, such as its solubility in various solvents, aids in optimizing its handling and formulation.
- The market for lipid-lowering therapy development is significantly influenced by compounds like Tert-Butyl Rosuvastatin, driving advancements in treatment efficacy.
Key Advantages
Enhancing Cardiovascular Treatment Efficacy
The use of Tert-Butyl Rosuvastatin in research for cardiovascular drug development supports the creation of more effective treatments for conditions like hyperlipidemia.
Quality Control in Pharmaceutical Production
As a known impurity, Tert-Butyl Rosuvastatin is essential for establishing robust quality control measures in the production of Rosuvastatin, ensuring product safety and consistency.
Facilitating Pharmaceutical Synthesis
The availability of high-purity Rosuvastatin intermediate synthesis pathways, often involving compounds like Tert-Butyl Rosuvastatin, is critical for efficient drug manufacturing.
Key Applications
Cardiovascular Disease Medication Development
Tert-Butyl Rosuvastatin serves as a critical impurity and metabolite in the development and quality assurance of medications aimed at treating dyslipidemia and other cardiovascular risks.
Pharmaceutical Research and Development
Its role in Rosuvastatin metabolism and its physicochemical properties make it valuable for R&D focused on optimizing drug formulations and delivery systems.
Lipid Management Therapies
As an integral part of the Rosuvastatin family, Tert-Butyl Rosuvastatin indirectly contributes to advancements in therapies designed to lower cholesterol and triglycerides.
Quality Control of Active Pharmaceutical Ingredients (APIs)
Accurate quantification and management of impurities like Tert-Butyl Rosuvastatin are paramount for ensuring the safety and efficacy of APIs in pharmaceutical manufacturing.